Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pain 3Carcinoma, Hepatocellular 3Prostatic Neoplasms 1Pain, Postoperative 1Inflammation 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Fentanyl 9Acetaminophen 5Zoledronic Acid 4Oxycodone 4Ketamine 4Bupivacaine 4Sufentanil 3Hydromorphone 3Diclofenac 3Ropivacaine 2Pregabalin 2Morphine 2Ketorolac 2Ibuprofen 2Ibandronic Acid 2Esketamine 2Epinephrine 2naloxegol 1chloroprocaine 1acetaminophen, aspirin, caffeine drug combination 1Varenicline 1Uterine Artery Embolization 1Ultracet 1Therapeutics 1Propofol 1Pamidronate 1Oxygen 1Nitrous Oxide 1Naproxen 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Pain × Sufentanil × Clear all
NCT06041425 2024-02-28

The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

The First Affiliated Hospital with Nanjing Medical University

Phase 4 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Inflammation, Pain

NCT05670561 2023-03-29

Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma

The Second Affiliated Hospital of Chongqing Medical University

Phase 4 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pain

NCT05416073 2023-02-24

TACE-HAIC

The Second Affiliated Hospital of Chongqing Medical University

Phase 4 Unknown
70 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡